1. Taiwan, Province of China Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
We Can Medicines Co., Ltd.

We Can Medicines Co., Ltd.

6929.TWO
We Can Medicines Co., Ltd.TW flagTaipei Exchange
23.35
TWD
+1.15
- -
1.05BMarket Cap
We Can Medicines Co., Ltd.
6929.TWO
(Taipei Exchange)

Recent

price

23.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
FRC
83.05
69.86
82.57
78.07
75.23
- -
71.81
Revenue per Share
1.33
0.97
2.5
0.37
-1.09
- -
-1.63
Basic EPS, GAAP
0.56
2.86
5.59
1.15
4.41
- -
4.55
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.28
- -
- -
Dividend per Share
9.53
8.63
11.2
11.57
10.39
- -
8.44
Book Value per Share
19.79
16.88
19.67
20.31
25.52
- -
23.27
Tangible Book Value per Share
32
40
40
40
43
- -
45
Basic Weighted Avg Shares
2,667
2,794
3,303
3,123
3,269
3,222
3,222
Sales/Revenue/Turnover
1.3
1.09
3.67
0.69
-1.53
-2.1
-2.1
Operating Margin (%)
198
214
254
276
309
321
321
Depreciation Expense
43
39
100
15
-47
-73
-73
Net Income, GAAP
- -
- -
17.4
31.47
- -
- -
- -
Effective Tax Rate (%)
1.6
1.39
3.03
0.47
-1.44
-2.27
-2.27
Profit Margin (%)
346
219
254
246
543
502
502
Working Capital
497
717
852
964
1,001
937
937
LT Debt
646
685
792
816
1,116
1,048
1,048
Total Equity
- -
2.1
5.81
0.74
- -
- -
- -
Return on Invested Capital (%)
- -
4.8
8.4
1.88
- -
- -
- -
Return on Capital (%)
- -
11.92
25.23
3.25
-10.32
-17.64
-17.64
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
263
264
260
LT Borrowings
127
125
133
LT Finance Leases
870
847
804
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
45
45
Market Capitalization
1,516
1,348
1,543

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
1,433
1,434
1,450
Cash, Cash Equivalents & STI
300
278
286
Accounts Receivable, Net
184
190
193
Inventories
847
838
846
Total Current Liabilities
906
921
948
Payables & Accruals
- -
- -
- -
ST Debt
263
264
260
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
11.09%
-6.07%
Free Cash Flow
- -
174.93%
6.61%
Net Income, GAAP
- -
-59.99%
55.19%
Sales/Revenue/Turnover
- -
4.15%
-1.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
772
765
774
812
3,123
2024
818
824
813
815
3,269
2025
798
817
790
818
3,222

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.48
-0.16
-0.1
- -
0.37
2024
0.27
-0.08
-0.47
- -
-1.09
2025
-0.28
-0.15
-0.58
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.28
2025
- -
- -
- -
- -
- -
Similar Companies
Comvita Limited (CVNZF)
Lotus Bakeries N.V. (LOTB.BR)
Palinda Group Holdings Limited (8179.HK)
Elamex S.A. de CV (ELAMF)
Farmmi, Inc. (FAMI)
Calbee, Inc. (CBCFF)
Business
We Can Medicines Co., Ltd. oversees a network of health and beauty retail outlets across Taiwan. The firm supplies a diverse selection of items, encompassing pharmaceuticals, various health-enhancing foods, goods for mothers and infants, and medical apparatus. They market products under their proprietary VITALPLUS line and also feature items from the Sapporo brand. Founded in 1987, the company maintains its primary offices in Taichung, Taiwan. We Can Medicines Co., Ltd. commenced trading on the Taipei Exchange with the ticker 6929 in March 2024. The enterprise operates as a division of Yousheng Medical Technology Co., Ltd.